Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHPA Seeks Ephedra Rule Stay For Traditional Herbs Labeled As Supplements

This article was originally published in The Tan Sheet

Executive Summary

AHPA has petitioned the FDA to stay its ephedra ban "only insofar as it pertains to traditional herbal formulas" marketed to licensed health care practitioners
Advertisement

Related Content

AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
Ephedra Ban Effective In April; FDA Will Follow-Up On Internet Firms
Ephedra Ban Effective In April; FDA Will Follow-Up On Internet Firms

Topics

Advertisement
UsernamePublicRestriction

Register

PS096598

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel